The largest trial yet of how to deliver long COVID care produced two findings that pull in opposite directions on cost, and the less encouraging one is probably the more useful.
Patients attending specialist multidisciplinary long COVID clinics showed meaningful improvement in fatigue over 12 weeks. Adding a comprehensive multi-organ MRI scan on top of that care improved neither fatigue nor quality of life. The trial, called STIMULATE-ICP, was published in Nature Medicine by researchers and clinicians at University College London and University College London Hospitals.
For patients who have spent years being told that nothing can be done, and for health systems deciding what to fund, those results matter in different ways. The scan finding carries immediate practical weight.
What the Trial Tested
More than 1,100 adults receiving care through six NHS long COVID clinics in England took part, making this the largest trial to compare approaches to delivering long COVID care rather than testing a drug.
The design was a cluster randomized phase 3 trial, meaning randomization happened at the level of primary care networks rather than individual patients, so that each approach was delivered as the standard of care in a given area. There were four groups: usual specialist care plus a multi-organ MRI scan, usual specialist care plus a digitally delivered rehabilitation program, both additions together, and usual specialist care alone.
The primary endpoint was the Fatigue Assessment Scale at 12 weeks. Fatigue was chosen because it is the most common long COVID symptom and the one patients most often identify as limiting their quality of life.
Fatigue improved across all four groups over the first 12 weeks. The journal's summary of the paper states that the trial found specialist Long COVID care improved fatigue response in all arms. Roughly 60 percent of participants met the threshold for clinically meaningful improvement. The digital rehabilitation program produced small but statistically significant additional gains by 24 weeks.
The Scan Result Is the More Useful Finding
Multi-organ MRI has been an appealing idea in long COVID for a specific reason. Earlier research reported that a large share of people with long COVID show evidence of mild impairment in at least one organ, which suggested that finding the impairment might direct treatment.
This trial tested that logic, and it did not hold. Scanning did not translate into better fatigue or better quality of life. The researchers offered a plausible explanation in the announcement of the results, noting that they found no evidence that routinely adding comprehensive multi-organ MRI scans improves outcomes, and suggesting this could be because it is not yet known how best to treat the multi-organ dysfunction the scans detect.
That is a distinction patients rarely get told clearly. A test that reliably finds something is not the same as a test that helps, and it is only worth doing when the result would change what happens next. For a person considering paying out of pocket for extensive imaging, or pressing a clinician to order it, this is the most directly actionable result in the paper.
Extensive imaging is not risk-free either. It carries cost, time, and a meaningful chance of incidental findings that trigger further tests and anxiety without improving anything.
Why "Specialist Care Works" Overstates What This Shows
The framing that specialist long COVID care reduces fatigue is the version most likely to circulate, and it goes slightly beyond the design.
Every group in this trial received specialist multidisciplinary care. There was no group that received none. That means the trial can say with confidence which additions helped, because those were randomized against each other, but it cannot isolate the effect of specialist care itself from the natural course of the condition, from regression to the mean among people who enrolled while feeling particularly unwell, or from the general effect of being enrolled in a study with regular contact.
Improvement across all arms is genuinely encouraging for patients who have been told long COVID does not improve. It is not the same as proof that the clinics caused the improvement, and the trial was not built to answer that question.
The condition itself remains poorly defined, and a separate arm of the same research program tested repurposed drugs, including colchicine, antihistamines, and rivaroxaban, finding only small short-term effects that faded after treatment stopped.
What This Means in a System That Works Differently
The trial ran inside a national health system with dedicated long COVID clinics, referral pathways, and multidisciplinary teams built as a matter of policy. England had established specialist clinics numbering in the dozens across the country.
The United States does not have that structure. Long COVID care here is delivered through a patchwork of academic post-COVID clinics concentrated in major metro areas, individual specialists, and primary care. Access depends heavily on insurance, geography, and whether a nearby health system chose to build a program. Waiting lists at the clinics that exist are frequently long.
That difference cuts both ways when reading this trial. The finding that coordinated multidisciplinary care is associated with improvement is an argument for building more of it. The finding that expensive imaging adds nothing is directly transferable and arguably more relevant here, because in a fee-for-service system the incentive to order more testing is stronger than in the NHS.
Patients most likely to be affected are those in the middle of this problem in America: sick enough to need coordinated care, without access to a specialist clinic, and vulnerable to being sold extensive diagnostic workups by clinics that market to long COVID patients directly.
What Patients Can Take from It
Nobody should stop or start anything on the basis of one trial, and this one does not identify a treatment.
What it reasonably supports is asking a clinician what a proposed scan would change. If the answer is that the result would not alter management, that is a reason to reconsider, particularly if the cost falls on the patient. It also supports pursuing coordinated care over fragmented specialist visits where that option exists, and asking a primary care clinician for a referral to a post-COVID program rather than assembling one specialist at a time.
Structured rehabilitation showed a small benefit at 24 weeks, and rehabilitation for long COVID needs to be paced carefully, since post-exertional symptom worsening is common and pushing through it can set people back. That is a conversation for a clinician who understands the condition.
Symptoms that warrant prompt evaluation rather than waiting include chest pain, new or worsening shortness of breath at rest, fainting, and a new racing heart rate on standing.
Researchers are calling for standardized definitions and outcome measures so trials in this field can be compared. Until that exists, results will continue to look inconsistent across studies that are measuring different things.
Frequently Asked Questions
What did the trial find? Fatigue improved over 12 weeks across all groups receiving specialist long COVID care. Adding a comprehensive multi-organ MRI scan improved neither fatigue nor quality of life. A digital rehabilitation program produced small additional gains by 24 weeks.
Does this prove specialist clinics work? Not on its own. Every group received specialist care, so the trial cannot separate that effect from the natural course of the condition or from study participation.
Should I ask for a multi-organ MRI? This trial found no benefit from adding one routinely. Ask a clinician what the result would change before pursuing extensive imaging.
Where was it done? Six NHS long COVID clinics in England, with more than 1,100 participants. US long COVID care is organized very differently.
Is there a treatment for long COVID? No established drug treatment. A related trial of colchicine, antihistamines, and rivaroxaban found only small short-term effects that faded after treatment stopped.
What about rehabilitation? The digital rehabilitation program showed a small benefit at 24 weeks. Rehabilitation needs careful pacing because post-exertional worsening is common.
When should I seek urgent care? Chest pain, new shortness of breath at rest, fainting, or a new racing heart rate on standing warrant prompt medical evaluation.
